Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rang in aandelen
#3671
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Aandeelprijs
$3.62
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$4.58B
Verandering (1 dag)
-0.16%
Verandering (1 jaar)
-53.07%
Land
CN
Handel Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categorie
Healthcare
EPS voor Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
EPS per June 2026 TTM: $-0.04
Volgens de laatste financiële rapporten en de aandelenkoers van Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is de huidige EPS van het bedrijf (TTM) $-0.04. Eind 2023 had het bedrijf een EPS van $0.14, een daling ten opzichte van de EPS van 2022 die $0.55 bedroeg.
EPS-geschiedenis van Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. van 2013 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $-0.04 | -535.00% |
| 2024 | $0.01 | -92.14% |
| 2023 | $0.14 | -74.54% |
| 2022 | $0.55 | 112.95% |
| 2021 | $0.26 | 195.53% |
| 2020 | $0.09 | 219.78% |
| 2019 | $0.03 | -30.53% |
| 2018 | $0.04 | 70.13% |
| 2017 | $0.02 | 14.36% |
| 2016 | $0.02 | 9.19% |
| 2015 | $0.02 | -4.64% |
| 2014 | $0.02 | 45.86% |
| 2013 | $0.01 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $17.32 | -39,916.09% |
US
|
|
| $-7.98 | 18,244.83% |
US
|
|
| $-5.29 | 12,060.92% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -63,870.11% |
NL
|
